XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (50,297) $ (35,912)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity in losses (earnings) of unconsolidated entities 11,902 (4,366)
Loss on sale of assets, net 13 124
Equity-based compensation 2,340 895
Depreciation and amortization 20,521 20,135
Asset impairment 0 141
Change in deferred income taxes 1,337 1,547
Change in fair value of non-hedge derivative 0 1,125
Amortization of deferred financing costs 1,929 1,429
Amortization of bond discount 1,426 1,045
Provision for (benefit from) credit losses 169 (165)
Change in:    
Accounts receivable 1,907 (10,825)
Other assets (4,289) 8,140
Accounts payable and accrued liabilities 9,206 6,700
Other liabilities (47) (2,157)
Net cash used in operating activities (3,883) (12,144)
Cash flows from investing activities:    
Investment in unconsolidated entities (611) (2,126)
Acquisition of consolidated subsidiary 0 (4,448)
Acquisition of leasing equipment (396) 0
Acquisition of property, plant and equipment (12,859) (39,861)
Investment in promissory notes and loans 0 (20,500)
Investment in equity instruments (5,000) 0
Proceeds from sale of property, plant and equipment 20 93
Net cash used in investing activities (18,846) (66,842)
Cash flows from financing activities:    
Proceeds from debt 0 41,600
Payments of Financing Costs 265 649
Cash dividends - common stock 0 (3,084)
Settlement of equity-based compensation (189) (90)
Net cash (used in) provided by financing activities (454) 37,777
Net decrease in cash and cash equivalents and restricted cash (23,183) (41,209)
Cash and cash equivalents and restricted cash, beginning of period 87,479 149,642
Cash and cash equivalents and restricted cash, end of period 64,296 108,433
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment 0 (2,245)
Dividends and accretion of redeemable preferred stock (16,975) (14,570)
Non-cash change in equity method investment (21,115) 52,852
Noncash Common Stock Dividends Accrued, Paid in Subsequent Quarter (3,051) 0
Noncash Payment for Settlement of Equity Based Compensation $ (3,027) $ 0